Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1COHANCE LIFESCIENCES LIMITED Hyderabad IN
02 1APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
03 1ASTELLAS PHARMA INC. Tokyo JP
04 1BIOINDUSTRIA L.I.M. S.P.A. Novi Ligure IT
05 2CIPLA LIMITED Mumbai IN
06 1DONG BANG FUTURE TECH & LIFE CO., LTD. Hwaseong-si KR
07 1LEE PHARMA LIMITED Hyderabad IN
08 1MACLEODS PHARMACEUTICALS LIMITED Mumbai IN
09 1PCAS Longjumeau FR
10 1QUIMICA SINTETICA S.A. Alcala De Henares ES
11 1SCINOPHARM TAIWAN, LTD. Shan-Hua TW
12 1SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN
13 1SUVEN PHARMACEUTICALS LIMITED Hyderabad IN
14 1SWATI SPENTOSE PVT. LTD. Mumbai IN
15 1SYNTHON BV Nijmegen NL
16 1TYCHE INDUSTRIES LIMITED Hyderabad IN
17 1Unichem Laboratories Limited Mumbai IN
18 1VASUDHA PHARMA CHEM LIMITED Hyderabad IN
19 1Wockhardt Limited Mumbai IN
20 1ZENTIVA K.S. Prague CZ
21 1ZENTIVA K.S. Praha 10 CZ
22 1ZYDUS LIFESCIENCES LIMITED Vadodara IN
01 20Tamsulosin hydrochloride
02 1Tamsulosin hydrochloride, A Code
03 1Tamsulosin hydrochloride, Ankleshwar site
04 1Tamsulosin hydrochloride, C code
01 2Czech Republic
02 1France
03 14India
04 1Italy
05 1Japan
06 1Netherlands
07 1South Korea
08 1Spain
09 1Taiwan
01 21Valid
02 2Withdrawn by Holder
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Certificate Number : R1-CEP 2012-309 - Rev 02
Status : Valid
Issue Date : 2022-12-15
Type : Chemical
Substance Number : 2131
Certificate Number : CEP 2007-253 - Rev 05
Status : Valid
Issue Date : 2024-10-24
Type : Chemical
Substance Number : 2131
Certificate Number : CEP 2022-152 - Rev 00
Status : Valid
Issue Date : 2023-12-12
Type : Chemical
Substance Number : 2131
Certificate Number : CEP 2022-185 - Rev 00
Status : Valid
Issue Date : 2023-12-06
Type : Chemical
Substance Number : 2131
Certificate Number : CEP 2019-004 - Rev 04
Status : Valid
Issue Date : 2024-12-04
Type : Chemical
Substance Number : 2131
Certificate Number : CEP 2011-004 - Rev 02
Status : Valid
Issue Date : 2024-09-11
Type : Chemical
Substance Number : 2131
Certificate Number : CEP 2022-133 - Rev 01
Status : Valid
Issue Date : 2024-09-13
Type : Chemical
Substance Number : 2131
Certificate Number : R0-CEP 2021-149 - Rev 00
Status : Valid
Issue Date : 2022-11-07
Type : Chemical
Substance Number : 2131
Certificate Number : CEP 2022-384 - Rev 00
Status : Valid
Issue Date : 2024-10-22
Type : Chemical
Substance Number : 2131
Certificate Number : R1-CEP 2007-234 - Rev 00
Status : Valid
Issue Date : 2014-03-07
Type : Chemical
Substance Number : 2131
A Tamsulosin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tamsulosin Hydrochloride, including repackagers and relabelers. The FDA regulates Tamsulosin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tamsulosin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tamsulosin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tamsulosin Hydrochloride supplier is an individual or a company that provides Tamsulosin Hydrochloride active pharmaceutical ingredient (API) or Tamsulosin Hydrochloride finished formulations upon request. The Tamsulosin Hydrochloride suppliers may include Tamsulosin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Tamsulosin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tamsulosin Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Tamsulosin Hydrochloride Certificate of Suitability (COS). The purpose of a Tamsulosin Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tamsulosin Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tamsulosin Hydrochloride to their clients by showing that a Tamsulosin Hydrochloride CEP has been issued for it. The manufacturer submits a Tamsulosin Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tamsulosin Hydrochloride CEP holder for the record. Additionally, the data presented in the Tamsulosin Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tamsulosin Hydrochloride DMF.
A Tamsulosin Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tamsulosin Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tamsulosin Hydrochloride suppliers with CEP (COS) on PharmaCompass.
We have 20 companies offering Tamsulosin Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?